Frontiers in targeting glioma stem cells

Research output: Contribution to journalArticlepeer-review


Patients with glioblastoma multiforme (GBM - WHO grade IV) seldom recover. This is due to the infiltrative nature of these tumours and the presence of cellular populations with ability to escape therapies and drive tumour recurrence and progression. In some cases, these resistant cells exhibit stem properties [glioma stem cells (GSC)]. This article aims at discussing relevant issues on GSC resistance to current therapies and outlines possible and promising avenues in regard to novel therapeutic strategies, such as pharmacological, immunological and viral interventions.

Original languageEnglish
Pages (from-to)496-507
Number of pages12
JournalEuropean Journal of Cancer
Issue number4
Publication statusPublished - Mar 2011


  • Cancer
  • CD133
  • Glioma
  • Resistance
  • Stem

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Fingerprint Dive into the research topics of 'Frontiers in targeting glioma stem cells'. Together they form a unique fingerprint.

Cite this